UA98498U - The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups - Google Patents

The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups

Info

Publication number
UA98498U
UA98498U UAU201412989U UAU201412989U UA98498U UA 98498 U UA98498 U UA 98498U UA U201412989 U UAU201412989 U UA U201412989U UA U201412989 U UAU201412989 U UA U201412989U UA 98498 U UA98498 U UA 98498U
Authority
UA
Ukraine
Prior art keywords
correction
age groups
menopausal disorders
perimenopausal women
postmenopausal age
Prior art date
Application number
UAU201412989U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ольга Григорівна Горбатюк
Анеля Станіславівна Шатковська
Анатолій Петрович Григоренко
Original Assignee
Вінницький Національний Медичний Університет Ім. М.І. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вінницький Національний Медичний Університет Ім. М.І. Пирогова filed Critical Вінницький Національний Медичний Університет Ім. М.І. Пирогова
Priority to UAU201412989U priority Critical patent/UA98498U/en
Publication of UA98498U publication Critical patent/UA98498U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups is the use of estrogen-progestagen complex preparations in the form of skin patch application, containing 600 mcg of ethinyl estradiol and 6000 mg norelgestromina 1 time per month for up to 3 years.
UAU201412989U 2014-12-04 2014-12-04 The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups UA98498U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201412989U UA98498U (en) 2014-12-04 2014-12-04 The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201412989U UA98498U (en) 2014-12-04 2014-12-04 The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups

Publications (1)

Publication Number Publication Date
UA98498U true UA98498U (en) 2015-04-27

Family

ID=53502212

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201412989U UA98498U (en) 2014-12-04 2014-12-04 The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups

Country Status (1)

Country Link
UA (1) UA98498U (en)

Similar Documents

Publication Publication Date Title
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
PH12018502634A1 (en) Topical compositions of apremilast
CA2956871C (en) Compounds active towards bromodomains
MX2017016376A (en) Piperidine derivative and preparation method and pharmaceutical use thereof.
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
WO2016190683A8 (en) Composition for preventing and treating muscle diseases or improving muscular function, containing platycodon grandiflorum extract
IN2014MU00303A (en)
MX2017006437A (en) Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain.
PH12018501237A1 (en) Isoindole compounds
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4275746A3 (en) Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
PH12019501724A1 (en) Estrogen receptor modulators
ZA202104166B (en) Sulcardine administration for treatment of acute atrial fibrillation
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
MX2018008643A (en) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
EP3597207A4 (en) Traditional chinese medicine composition for treating tumours, preparation method therefor and use thereof
MX2020000636A (en) Synthetic proteins and therapeutic uses thereof.
MX2022005250A (en) Therapeutic combinations of acalabrutinib and capivasertib to treat b-cell malignancies.
PH12018502139A1 (en) Phosphaplatin liquid formulations
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
UA98498U (en) The process of correction of menopausal disorders in perimenopausal women and postmenopausal age groups
MX2018008196A (en) Treatment of breast cancer using a combination of a cationic liposomal formulation of taxane, a non-liposomal formulation of taxane and a further active agent.